Skip to main content
Erschienen in: Journal of Endocrinological Investigation 9/2023

05.04.2023 | Original Article

Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas

verfasst von: H. Wang, J. Chang, W. Zhang, Y. Fang, S. Li, Y. Fan, S. Jiang, Y. Yao, K. Deng, L. Lu, X. Bao, F. Feng, R. Wang, M. Feng

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

Silent corticotroph adenomas (SCAs) are a subtype of nonfunctioning pituitary adenomas that exhibit more aggressive behavior. However, rapid and accurate preoperative diagnostic methods are currently lacking.

Design

The purpose of this study was to examine the differences between SCA and non-SCA features and to establish radiomics models and a clinical scale for rapid and accurate prediction.

Methods

A total of 260 patients (72 SCAs vs. 188 NSCAs) with nonfunctioning adenomas from Peking Union Medical College Hospital were enrolled in the study as the internal dataset. Thirty-five patients (6 SCAs vs. 29 NSCAs) from Fuzhou General Hospital were enrolled as the external dataset. Radiomics models and an SCA scale to preoperatively diagnose SCAs were established based on MR images and clinical features.

Results

There were more female patients (internal dataset: p < 0.001; external dataset: p = 0.028) and more multiple microcystic changes (internal dataset: p < 0.001; external dataset: p = 0.012) in the SCA group. MRI showed more invasiveness (higher Knosp grades, p ≤ 0.001). The radiomics model achieved AUCs of 0.931 and 0.937 in the internal and external datasets, respectively. The clinical scale achieved an AUC of 0.877 and a sensitivity of 0.952 in the internal dataset and an AUC of 0.899 and a sensitivity of 1.0 in the external dataset.

Conclusions

Based on clinical information and imaging characteristics, the constructed radiomics model achieved high preoperative diagnostic ability. The SCA scale achieved the purpose of rapidity and practicality while ensuring sensitivity, which is conducive to simplifying clinical work.
Literatur
1.
Zurück zum Zitat Lopes MJ, Bs AN (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521PubMedCrossRef Lopes MJ, Bs AN (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521PubMedCrossRef
3.
Zurück zum Zitat Horvath E et al (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Endocrine 98(3):617–638 Horvath E et al (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Endocrine 98(3):617–638
4.
Zurück zum Zitat Righi A et al (2016) The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3. Endocrine 56(2):1–12 Righi A et al (2016) The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3. Endocrine 56(2):1–12
5.
Zurück zum Zitat Raverot G et al (2010) Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing’s disease. Euro J Endocrinol. 163(1):35CrossRef Raverot G et al (2010) Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing’s disease. Euro J Endocrinol. 163(1):35CrossRef
6.
Zurück zum Zitat Cheres AE et al (2017) Perioperative hypothalamic pituitary adrenal function in patients with silent. corticotroph adenomas 20(4):471–476 Cheres AE et al (2017) Perioperative hypothalamic pituitary adrenal function in patients with silent. corticotroph adenomas 20(4):471–476
7.
Zurück zum Zitat Yamada S et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580PubMedCrossRef Yamada S et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580PubMedCrossRef
8.
Zurück zum Zitat Cho HY et al (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning. pituitary adenomas 72(5):648–653 Cho HY et al (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning. pituitary adenomas 72(5):648–653
9.
Zurück zum Zitat Langlois F et al (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors a large single center experience. Endocrine 58:534CrossRef Langlois F et al (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors a large single center experience. Endocrine 58:534CrossRef
10.
Zurück zum Zitat Arman J et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 1:17–18 Arman J et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 1:17–18
11.
Zurück zum Zitat Jiang S, Zhu J, Feng M, Yao Y, Deng K, Xing B, Lian W, Wang R, Bao X (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564–573PubMedCrossRef Jiang S, Zhu J, Feng M, Yao Y, Deng K, Xing B, Lian W, Wang R, Bao X (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564–573PubMedCrossRef
12.
Zurück zum Zitat Cazabat L et al (2014) Silent, but not unseen:Multi-microcystic aspect on T2-weighted MRI in Silent Corticotroph Adenomas. Clinical Endocrinol 81(4):566–572CrossRef Cazabat L et al (2014) Silent, but not unseen:Multi-microcystic aspect on T2-weighted MRI in Silent Corticotroph Adenomas. Clinical Endocrinol 81(4):566–572CrossRef
13.
Zurück zum Zitat Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26:349–355PubMedCrossRef Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26:349–355PubMedCrossRef
14.
Zurück zum Zitat He, W., et al., Development and Evaluation of Deep Learning-based Automated Segmentation of Pituitary Adenoma in Clinical Task. (9): p. 9. He, W., et al., Development and Evaluation of Deep Learning-based Automated Segmentation of Pituitary Adenoma in Clinical Task. (9): p. 9.
15.
Zurück zum Zitat Fan Y et al (2019) Machine learning-based radiomics predicts radiotherapeutic response in patients with acromegaly. Front Endocrinol (Lausanne) 10:588PubMedCrossRef Fan Y et al (2019) Machine learning-based radiomics predicts radiotherapeutic response in patients with acromegaly. Front Endocrinol (Lausanne) 10:588PubMedCrossRef
16.
Zurück zum Zitat Fan Y et al (2019) Preoperative noninvasive radiomics approach predicts tumor consistency in patients with acromegaly: development and multicenter prospective validation. Front Endocrinol (Lausanne) 10:403PubMedCrossRef Fan Y et al (2019) Preoperative noninvasive radiomics approach predicts tumor consistency in patients with acromegaly: development and multicenter prospective validation. Front Endocrinol (Lausanne) 10:403PubMedCrossRef
17.
Zurück zum Zitat Ugga L et al (2019) Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning. Front Endocrinol 61(12):1365–1373 Ugga L et al (2019) Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning. Front Endocrinol 61(12):1365–1373
18.
Zurück zum Zitat Cuocolo R et al (2020) Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI. Neuroradiology 62:1649PubMedPubMedCentralCrossRef Cuocolo R et al (2020) Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI. Neuroradiology 62:1649PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Ajp A et al (2020) A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging. Sci Direct. 125:453 Ajp A et al (2020) A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging. Sci Direct. 125:453
20.
Zurück zum Zitat Bahuleyan B et al (2006) To assess the ability of MRI to predict consistency of pituitary macroadenomas. Sci Direct 20(5):324–326 Bahuleyan B et al (2006) To assess the ability of MRI to predict consistency of pituitary macroadenomas. Sci Direct 20(5):324–326
21.
Zurück zum Zitat Griethuysen JJMV et al (2017) Computational Radiomics System to Decode the Radiographic. Phenotype 77(21):e104–e107 Griethuysen JJMV et al (2017) Computational Radiomics System to Decode the Radiographic. Phenotype 77(21):e104–e107
22.
Zurück zum Zitat Braileanu M et al (2019) Pre-operative MRI predictors of hormonal remission status post pituitary. adenoma resec 55:29–34 Braileanu M et al (2019) Pre-operative MRI predictors of hormonal remission status post pituitary. adenoma resec 55:29–34
23.
Zurück zum Zitat Hui Z, Hastie T (2012) elasticnet Elastic-Net for Sparse Estimation and Sparse PCA. Mach Learn 45:554 Hui Z, Hastie T (2012) elasticnet Elastic-Net for Sparse Estimation and Sparse PCA. Mach Learn 45:554
24.
25.
Zurück zum Zitat Geurts P, Ernst D, Wehenkel LJML (2006) Extremely randomized trees 63(1):3–42 Geurts P, Ernst D, Wehenkel LJML (2006) Extremely randomized trees 63(1):3–42
26.
Zurück zum Zitat Quinlan JR (1986) Induction of decision trees. Mach Learn 1(1):81–106CrossRef Quinlan JR (1986) Induction of decision trees. Mach Learn 1(1):81–106CrossRef
27.
Zurück zum Zitat Friedman JHJCSD (2002) Stochastic gradient boosting. Mach Learn 38(4):367–378 Friedman JHJCSD (2002) Stochastic gradient boosting. Mach Learn 38(4):367–378
28.
Zurück zum Zitat Schapire RE, Singer Y (2000) BoosTexter: a boosting-based system for text categorization. Mach Learn 39(2/3):135–168CrossRef Schapire RE, Singer Y (2000) BoosTexter: a boosting-based system for text categorization. Mach Learn 39(2/3):135–168CrossRef
29.
Zurück zum Zitat Gardner MW, Dorling SJA (1998) Artificial neural networks (the multilayer perceptron). A rev appl atmo sci. 32:2627–2636 Gardner MW, Dorling SJA (1998) Artificial neural networks (the multilayer perceptron). A rev appl atmo sci. 32:2627–2636
30.
Zurück zum Zitat Chen, T. and C. Guestrin, 2016 XGBoost, in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 785–794. Chen, T. and C. Guestrin, 2016 XGBoost, in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 785–794.
31.
Zurück zum Zitat Rodríguez-Pérez R, JBJC. Design, 2020 Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. 34(10): 1013–1026. Rodríguez-Pérez R, JBJC. Design, 2020 Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. 34(10): 1013–1026.
32.
Zurück zum Zitat Sullivan L.M., J.M. Massaro, and R.B.D.A.J.S.i.M. Sr., 2010 Presentation of multivariate data for clinical use: The Framingham Study risk score functions. 23(10): 1631–1660. Sullivan L.M., J.M. Massaro, and R.B.D.A.J.S.i.M. Sr., 2010 Presentation of multivariate data for clinical use: The Framingham Study risk score functions. 23(10): 1631–1660.
33.
Zurück zum Zitat Woodward M (2013) Epidemiology: study design and data analysis. CRC press Woodward M (2013) Epidemiology: study design and data analysis. CRC press
34.
Zurück zum Zitat Fang Y, Pei Z, Chen H, Wang R, Feng M, Wei L, Li J, Zhang H, Wang S (2021) Diagnostic value of knosp grade and modified knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta-analysis. Pituitary 24(3):457–464PubMedCrossRef Fang Y, Pei Z, Chen H, Wang R, Feng M, Wei L, Li J, Zhang H, Wang S (2021) Diagnostic value of knosp grade and modified knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta-analysis. Pituitary 24(3):457–464PubMedCrossRef
35.
Zurück zum Zitat Athanasios F et al (2018) Recurrence of Silent Corticotroph Adenomas After Primary Treatment: A Systematic Review. Meta-Analysis 4:4 Athanasios F et al (2018) Recurrence of Silent Corticotroph Adenomas After Primary Treatment: A Systematic Review. Meta-Analysis 4:4
36.
Zurück zum Zitat Bradley KJ, Wass JAH, Turner HEJCE (2010) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clinical Endocrinol 58(1):665 Bradley KJ, Wass JAH, Turner HEJCE (2010) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clinical Endocrinol 58(1):665
37.
Zurück zum Zitat Li H, Zhao Q, Zhang Y, Sai K, Xu L, Mou Y et al (2021) Image-driven classification of functioning and nonfunctioning pituitary adenoma by deep convolutional neural networks. Computat Struct Biotech J 19:3077–3086CrossRef Li H, Zhao Q, Zhang Y, Sai K, Xu L, Mou Y et al (2021) Image-driven classification of functioning and nonfunctioning pituitary adenoma by deep convolutional neural networks. Computat Struct Biotech J 19:3077–3086CrossRef
38.
Zurück zum Zitat Kasuki L et al (2019) Accuracy of microcystic aspect on T2 eighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol 92(2):676 Kasuki L et al (2019) Accuracy of microcystic aspect on T2 eighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol 92(2):676
Metadaten
Titel
Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas
verfasst von
H. Wang
J. Chang
W. Zhang
Y. Fang
S. Li
Y. Fan
S. Jiang
Y. Yao
K. Deng
L. Lu
X. Bao
F. Feng
R. Wang
M. Feng
Publikationsdatum
05.04.2023
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 9/2023
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02042-2

Weitere Artikel der Ausgabe 9/2023

Journal of Endocrinological Investigation 9/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.